- Home
- FMS vs XPO Comparison
FMS vs XPO Comparison
Compare FMS & XPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- XPO
- Stock Information
- Founded
- FMS 1996
- XPO 2000
- Country
- FMS Germany
- XPO United States
- Employees
- FMS N/A
- XPO N/A
- Industry
- FMS Misc Health and Biotechnology Services
- XPO Transportation Services
- Sector
- FMS Health Care
- XPO Consumer Discretionary
- Exchange
- FMS Nasdaq
- XPO Nasdaq
- Market Cap
- FMS 12.3B
- XPO 11.8B
- IPO Year
- FMS 1996
- XPO N/A
- Fundamental
- Price
- FMS $22.17
- XPO $148.95
- Analyst Decision
- FMS Hold
- XPO Strong Buy
- Analyst Count
- FMS 2
- XPO 16
- Target Price
- FMS $23.00
- XPO $141.13
- AVG Volume (30 Days)
- FMS 324.5K
- XPO 1.5M
- Earning Date
- FMS 11-05-2024
- XPO 10-30-2024
- Dividend Yield
- FMS 2.86%
- XPO N/A
- EPS Growth
- FMS 46.47
- XPO 895.80
- EPS
- FMS 2.50
- XPO 3.08
- Revenue
- FMS $21,457,738,113.00
- XPO $8,090,000,000.00
- Revenue This Year
- FMS $0.24
- XPO $5.40
- Revenue Next Year
- FMS $3.41
- XPO $4.28
- P/E Ratio
- FMS $17.53
- XPO $48.28
- Revenue Growth
- FMS N/A
- XPO 5.96
- 52 Week Low
- FMS $17.93
- XPO $78.72
- 52 Week High
- FMS $22.76
- XPO $156.85
- Technical
- Relative Strength Index (RSI)
- FMS 64.02
- XPO 67.05
- Support Level
- FMS $21.42
- XPO $142.78
- Resistance Level
- FMS $21.48
- XPO $152.23
- Average True Range (ATR)
- FMS 0.30
- XPO 4.16
- MACD
- FMS 0.11
- XPO -0.71
- Stochastic Oscillator
- FMS 97.64
- XPO 68.55
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. On a pro forma basis for the RXO spinoff, We estimate LTL shipping now makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.